Complete resolution
81.8%
Complete resolution at 1-week follow-up in the published BPPV study.
Shan et al., The Laryngoscope, 2015
Evidence
VertiMotion is evidence-aware rather than hype-driven. Published data and mature-market usage signals should support discussion while clinical decisions remain independent.
Summary card
Shan et al., The Laryngoscope, 2015 reported outcomes from 132 patients aged 28-86 treated with a computer-controlled canalith repositioning procedure. The study reported 81.8% complete resolution and 88.6% vertigo resolution at 1 week, with 1.5% canal conversion and no significant adverse effects reported in the study.
Published BPPV evidence
These figures are included for executive review and should be interpreted in context of study design, population, follow-up period, and local clinical governance.
Complete resolution
81.8%
Complete resolution at 1-week follow-up in the published BPPV study.
Shan et al., The Laryngoscope, 2015
Vertigo resolution
88.6%
Vertigo resolution at 1 week in the same short-term study cohort.
Published short-term data
Canal conversion
1.5%
Canal conversion rate reported in the published study.
Individual results vary
Patients studied
132
Patients aged 28 to 86 treated with computer-controlled canalith repositioning.
Executive evidence snapshot
Published short-term study data. Individual results vary. This site does not imply guaranteed outcomes, regulatory approval, or suitability for every patient.
Study design
A concise view of the referenced BPPV publication for early-stage diligence.
Publication
Shan et al., The Laryngoscope, 2015
Cohort
132 patients
Age range
28-86
Intervention
Computer-controlled canalith repositioning procedure
Follow-up
Short-term 1-week follow-up data
Reported safety
No significant adverse effects reported in the study
Habituation
Controlled motion exposure can support selected habituation programs when patients are appropriately screened and supervised. VertiMotion frames this as a selected clinical program area, not a universal treatment claim.
Clinical posture
The platform language emphasizes support, standardization, protocol-driven execution, and clinical oversight. It avoids implying guaranteed outcomes or substituting for local clinician judgment.
Usage signals
Usage references can inform market diligence, but they are not a forecast of local demand or a substitute for pilot data.
Hospitals nationwide
711+
Mainland China mature-market adoption signal.
Patients treated
10M+
Reported cumulative usage since launch.
Total visits
25,819
Across 4 hospital sites in a published usage analysis.
Unique patients
13,447
Distinct patients across those hospital sites.
Protocol runs
42,346
Treatment protocol runs in the multi-site reference.
Safety and governance
Evidence review should sit alongside operator training, screening, incident process, and compliance review.
Recommended for pilot planning and clinical governance review.
Recommended for pilot planning and clinical governance review.
Recommended for pilot planning and clinical governance review.
Recommended for pilot planning and clinical governance review.
Recommended for pilot planning and clinical governance review.
Recommended for pilot planning and clinical governance review.
Recommended for pilot planning and clinical governance review.
Resources
Resource
Shan et al., The Laryngoscope, 2015. Computer-controlled canalith repositioning in 132 patients.
Resource
Room, power, operator, governance, and patient pathway checks for pilot planning.
Resource
How clinics can structure GP education, internal conversion, and demand generation around dizziness care.
Resource
Suggested metrics for pathway volume, protocol use, follow-up, and operational review.
Next step
Use the evidence brief as a starting point for independent clinical, regulatory, and pilot planning review.